Prof Shankar Siva
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
542 Scholarly works
8 Projects
HIGHLIGHTS
2026
Journal article
Neoadjuvant therapies for clear cell renal cell carcinoma: review of current evidence and future applications
DOI: 10.1007/s00345-026-06603-x2026
Journal article
Deep learning and radiomics models in patients with advanced non-small cell lung cancer treated with immunotherapy combined with stereotactic radiotherapy
DOI: 10.1038/s41598-026-53520-52026
Journal article
Inconsistent definitions of local control for stereotactic body radiation therapy for early-stage lung cancer – A systematic review
DOI: 10.1016/j.radonc.2026.1116952023
Research grants (ARC, NHMRC, MRFF)
Reducing the Impact of Radiation on the Heart for Cancer and Cardiac Disease Patients
2020
Research grants (other domestic)
Stereotactic Ablative Body Radiotherapy (Sabr) as a Catalyst to Improve Outcomes From Immunotherapy
2018
Journal article
Cold kit for prostate-Specific membrane antigen (PSMA) PET imaging: Phase 1 study of 68Ga-Tris (Hydroxypyridinone)-PSMA PET/CT in patients with prostate cancer
DOI: 10.2967/jnumed.117.1995542018
Research Grant
Stereotactic Ablative Radiotherapy (Sabr) as a New Precision Treatment Option in Kidney Cancer
RECENT SCHOLARLY WORKS
2026
Journal article
First Images on a Next-Generation Extended-Field-of-View Digital Bismuth Germanium Oxide Total-Body PET/CT
DOI: 10.2967/jnumed.125.2719952026
Journal article
A Response to the Letter to the Editor: Radiotherapy to the Primary, With or Without Total Metastatic Ablation
DOI: 10.1016/j.jtho.2026.1039262026
Journal article
Outcomes of stereotactic ablative body radiotherapy for treatment of oligometastatic gynecological cancers: a narrative review
DOI: 10.1016/j.ijgc.2026.1047902026
Journal article
Single-fraction or multi-fraction stereotactic ablative body radiotherapy followed by atezolizumab in advanced triple-negative breast cancer: a randomized phase II trial
DOI: 10.1038/s41467-026-75660-y2026
Journal article
Dynamic immune profiling predicts response to radiation plus anti-PD-1 therapy in oligometastatic renal cell carcinoma.
DOI: 10.1038/s41467-026-74255-x2026
Journal article
Stereotactic Ablative Radiotherapy (SABR) one stop service for lung cancer: A pilot study for early-stage Non-Small-Cell Lung Cancer (NSCLC)
DOI: 10.1016/j.radonc.2026.1115532026
Journal article
Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials
DOI: 10.1016/j.eururo.2026.03.024
RECENT PROJECTS
2025
Research grants (ARC, NHMRC, MRFF)
A Registry-Based Randomised Trial of Radiotherapy in Advanced Lung Cancer